• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测同时性结直肠癌肝局限性转移患者总生存期和癌症特异性生存期的列线图。

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis.

作者信息

Li Yuqiang, Liu Wenxue, Zhao Lilan, Güngör Cenap, Xu Yang, Song Xiangping, Wang Dan, Zhou Zhongyi, Zhou Yuan, Li Chenglong, Pei Qian, Tan Fengbo, Pei Haiping

机构信息

Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.

Department of General Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

J Cancer. 2020 Aug 27;11(21):6213-6225. doi: 10.7150/jca.46155. eCollection 2020.

DOI:10.7150/jca.46155
PMID:33033504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7532510/
Abstract

Colorectal cancer (CRC) ranks as the third most frequent cancer type and the second leading cause of cancer-related death worldwide. The liver is the most common metastatic site of CRC with 20%-34% of patients suffering synchronous liver metastasis. Patients with colorectal liver-limited metastasis account for one-third of deaths from colorectal cancer. Moreover, some evidence indicated that CRC patients with synchronous liver disease encounter a worse prognosis and more disseminated disease state comparing with metastatic liver disease that develops metachronously. Data in this retrospective analysis were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms were constructed with basis from a multivariate Cox regression analysis. The prognostic nomograms were validated by C-index, time-dependent receiver operating characteristic (ROC) curve, decision curve analysis (DCA) and calibration curves. A total of 9,958 CRC patients with synchronous liver-limited metastasis were extracted from the SEER database during 2010-2016. Both overall survival (OS) and cancer-specific survival (CSS) were significantly correlated with age, marital status, race, tumor location, pathological grade, histologic type, T stage, N stage, surgery for primary tumor, surgery for liver metastasis, chemotherapy and CEA. All of the significant variables were used to create the nomograms predicting OS and CSS. C-index values, time-dependent ROC curves, DCA curves and calibration curves, proved the superiority of the nomograms. Our research investigated a national cohort of almost 10,000 patients to create and verify nomograms based on pathological, therapeutic and demographic features to predict OS and CSS for synchronous colorectal liver-limited metastasis (SCLLM). The nomograms may act as an excellent tool to integrate clinical characteristics to guide the therapeutic choice for SCLLM patients.

摘要

结直肠癌(CRC)是全球第三大常见癌症类型,也是癌症相关死亡的第二大主要原因。肝脏是CRC最常见的转移部位,20%-34%的患者发生同步肝转移。结直肠肝局限性转移患者占结直肠癌死亡人数的三分之一。此外,一些证据表明,与异时性发生的转移性肝病相比,患有同步性肝病的CRC患者预后更差,疾病扩散程度更高。本回顾性分析的数据来自监测、流行病学和最终结果(SEER)数据库。根据多变量Cox回归分析构建列线图。通过C指数、时间依赖性受试者操作特征(ROC)曲线、决策曲线分析(DCA)和校准曲线对预后列线图进行验证。2010年至2016年期间,从SEER数据库中提取了9958例同步肝局限性转移的CRC患者。总生存期(OS)和癌症特异性生存期(CSS)均与年龄、婚姻状况、种族、肿瘤位置、病理分级、组织学类型、T分期、N分期、原发肿瘤手术、肝转移手术、化疗和癌胚抗原(CEA)显著相关。所有显著变量均用于创建预测OS和CSS的列线图。C指数值、时间依赖性ROC曲线、DCA曲线和校准曲线证明了列线图的优越性。我们的研究调查了近10000名患者的全国队列,以创建和验证基于病理、治疗和人口统计学特征的列线图,以预测同步结直肠肝局限性转移(SCLLM)的OS和CSS。这些列线图可能是整合临床特征以指导SCLLM患者治疗选择的优秀工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/9715030b016f/jcav11p6213g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/1b0de4a8af0c/jcav11p6213g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/4c667dedd3ca/jcav11p6213g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/f9237d18e2b6/jcav11p6213g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/a362ac645c0f/jcav11p6213g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/1456a93ab5e0/jcav11p6213g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/0c3d82bc6940/jcav11p6213g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/9715030b016f/jcav11p6213g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/1b0de4a8af0c/jcav11p6213g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/4c667dedd3ca/jcav11p6213g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/f9237d18e2b6/jcav11p6213g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/a362ac645c0f/jcav11p6213g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/1456a93ab5e0/jcav11p6213g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/0c3d82bc6940/jcav11p6213g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/218b/7532510/9715030b016f/jcav11p6213g007.jpg

相似文献

1
Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis.预测同时性结直肠癌肝局限性转移患者总生存期和癌症特异性生存期的列线图。
J Cancer. 2020 Aug 27;11(21):6213-6225. doi: 10.7150/jca.46155. eCollection 2020.
2
Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade.术前新辅助化疗的结直肠癌患者不同组织学分化程度的预后因素分析及中分化预后列线图的建立。
Int J Colorectal Dis. 2023 Sep 25;38(1):237. doi: 10.1007/s00384-023-04539-x.
3
Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.基于人群的研究:预测早发性结直肠癌伴同步肝转移患者癌症特异性生存的列线图。
Int J Colorectal Dis. 2022 Jun;37(6):1309-1319. doi: 10.1007/s00384-022-04175-x. Epub 2022 May 7.
4
Specific survival nomograms based on SEER database for small intestine adenocarcinoma.基于 SEER 数据库的小肠腺癌特定生存诺模图。
Ann Palliat Med. 2021 Jul;10(7):7440-7457. doi: 10.21037/apm-21-600. Epub 2021 Jul 14.
5
Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.不同转移状态的IV期直肠癌患者总生存的预后因素及个体化列线图预测:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Transl Cancer Res. 2022 Sep;11(9):3141-3155. doi: 10.21037/tcr-22-436.
6
Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: a large population-based analysis.建立列线图预测不可切除转移灶的结直肠癌肝转移患者局部肿瘤切除后的总生存期和癌症特异性生存期:一项基于大人群的分析
Discov Oncol. 2024 Jul 29;15(1):315. doi: 10.1007/s12672-024-01182-y.
7
Nomograms to predict survival after colorectal cancer resection without preoperative therapy.预测未经术前治疗的结直肠癌切除术后生存率的列线图。
BMC Cancer. 2016 Aug 19;16(1):658. doi: 10.1186/s12885-016-2684-4.
8
Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.同步肝转移的结直肠癌患者同时接受原发灶和转移灶手术治疗的生存列线图的开发与验证
Am J Cancer Res. 2021 Jun 15;11(6):2654-2669. eCollection 2021.
9
Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis.同步性结肠癌肝转移的预测风险因素及在线列线图
Front Oncol. 2020 Oct 2;10:1681. doi: 10.3389/fonc.2020.01681. eCollection 2020.
10
Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients.预测结直肠癌患者印戒细胞癌总生存期和特定病因生存期的预后列线图。
World J Clin Cases. 2021 Apr 16;9(11):2503-2518. doi: 10.12998/wjcc.v9.i11.2503.

引用本文的文献

1
Establishment and Validation of a Prognostic Nomogram for Predicting Postoperative Overall Survival in Advanced Stage III-IV Colorectal Cancer Patients.建立并验证预测 III-IV 期结直肠癌患者术后总生存期的列线图预后模型。
Cancer Med. 2024 Nov;13(22):e70385. doi: 10.1002/cam4.70385.
2
Development and validation of a risk predictive nomogram for colon cancer-specific mortality: a competing risk model based on the SEER database.结肠癌特异性死亡率风险预测列线图的开发与验证:基于监测、流行病学和最终结果(SEER)数据库的竞争风险模型
Discov Oncol. 2024 Nov 6;15(1):621. doi: 10.1007/s12672-024-01498-9.
3
miR‑25‑3p serves as an oncogenic in colorectal cancer cells by regulating the ubiquitin ligase FBXW7 function.

本文引用的文献

1
The main contributor to the upswing of survival in locally advanced colorectal cancer: an analysis of the SEER database.局部晚期结直肠癌生存率上升的主要因素:基于监测、流行病学和最终结果(SEER)数据库的分析
Therap Adv Gastroenterol. 2019 Jul 18;12:1756284819862154. doi: 10.1177/1756284819862154. eCollection 2019.
2
Prognostic and predictive markers in liver limited stage IV colorectal cancer.局限期肝转移 IV 期结直肠癌的预后和预测标志物。
Eur J Surg Oncol. 2019 Dec;45(12):2251-2256. doi: 10.1016/j.ejso.2019.06.038. Epub 2019 Jun 27.
3
Survival nomograms for stage III colorectal cancer.
miR-25-3p 通过调控泛素连接酶 FBXW7 的功能在结直肠癌细胞中发挥致癌作用。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8812. Epub 2024 Sep 27.
4
Nano-energy interference: A novel strategy for blunting tumor adaptation and metastasis.纳米能量干扰:一种抑制肿瘤适应性和转移的新策略。
Mater Today Bio. 2024 Feb 3;25:100984. doi: 10.1016/j.mtbio.2024.100984. eCollection 2024 Apr.
5
Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain.预测结直肠癌肝、肺、骨和脑转移患者总生存期的列线图。
Cancer Causes Control. 2023 Dec;34(12):1059-1072. doi: 10.1007/s10552-023-01744-5. Epub 2023 Jul 24.
6
Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy.介孔二氧化硅纳米颗粒作为癌症治疗的基因传递平台
Pharmaceutics. 2023 May 8;15(5):1432. doi: 10.3390/pharmaceutics15051432.
7
New Personal Model for Forecasting the Outcome of Patients with Histological Grade III-IV Colorectal Cancer Based on Regional Lymph Nodes.基于区域淋巴结的预测Ⅲ-Ⅳ级组织学结直肠癌患者预后的新型个体化模型
J Oncol. 2023 Feb 25;2023:6980548. doi: 10.1155/2023/6980548. eCollection 2023.
8
Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases.用于预测伴有肺转移的乳腺癌患者总生存期和癌症特异性生存期的基于网络的动态列线图
J Pers Med. 2022 Dec 26;13(1):43. doi: 10.3390/jpm13010043.
9
Development and Validation of Nomogram for Predicting Survival of Primary Liver Cancers Using Machine Learning.使用机器学习预测原发性肝癌生存的列线图的开发与验证
Front Oncol. 2022 Jun 20;12:926359. doi: 10.3389/fonc.2022.926359. eCollection 2022.
10
Discovering Innate Driver Variants for Risk Assessment of Early Colorectal Cancer Metastasis.发现用于早期结直肠癌转移风险评估的先天性驱动变异
Front Oncol. 2022 Jun 20;12:898117. doi: 10.3389/fonc.2022.898117. eCollection 2022.
III期结直肠癌的生存列线图。
Medicine (Baltimore). 2018 Dec;97(49):e13239. doi: 10.1097/MD.0000000000013239.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.RAS和BRAF野生型转移性结直肠癌患者中原发肿瘤的位置及抗表皮生长因子受体单克隆抗体的获益情况
Oncologist. 2016 Aug;21(8):988-94. doi: 10.1634/theoncologist.2016-0084. Epub 2016 Jul 5.
6
Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.与单纯化疗/放疗相比,IV期结直肠癌患者在未行转移灶切除术时进行原发肿瘤的手术切除与总生存期改善相关。
Dis Colon Rectum. 2016 Apr;59(4):299-305. doi: 10.1097/DCR.0000000000000546.
7
Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.管理结直肠癌的同步肝转移:多学科国际共识。
Cancer Treat Rev. 2015 Nov;41(9):729-41. doi: 10.1016/j.ctrv.2015.06.006. Epub 2015 Jun 30.
8
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.结肠癌的位置(右侧与左侧)作为预后因素和西妥昔单抗获益的预测因子在 NCIC CO.17 研究中的体现。
Eur J Cancer. 2015 Jul;51(11):1405-14. doi: 10.1016/j.ejca.2015.03.015. Epub 2015 May 12.
9
Primary tumor location as a prognostic factor in metastatic colorectal cancer.原发性肿瘤位置作为转移性结直肠癌的一个预后因素
J Natl Cancer Inst. 2015 Feb 24;107(3). doi: 10.1093/jnci/dju427. Print 2015 Mar.
10
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.原发肿瘤切除术是否能改善不可切除的结直肠癌同步转移患者的生存?来自四项随机试验的个体数据合并分析。
Eur J Cancer. 2015 Jan;51(2):166-76. doi: 10.1016/j.ejca.2014.10.023. Epub 2014 Nov 24.